Extra work of checking device data weekly does not translate into benefit for HF patient

Media formats available:

Epigenetics: A closer look at BET inhibition
Epigenetics: A closer look at BET inhibition
ESC 2016
Epigenetics: A closer look at BET inhibition
No indication for difference in efficacy between potent platelet inhibitors after PCI
No indication for difference in efficacy between potent platelet inhibitors after PCI
ESC 2016
No indication for difference in efficacy between potent platelet inhibitors after PCI
- Steen Dalby Kristensen, MD
To SPRINT or not to SPRINT to a lower blood pressure target?
To SPRINT or not to SPRINT to a lower blood pressure target?
CSI 2016 ESC
To SPRINT or not to SPRINT to a lower blood pressure target?
Beyond statins: The role of ezetimibe in targeting residual risk
Beyond statins: The role of ezetimibe in targeting residual risk
ESC 2016
Beyond statins: The role of ezetimibe in targeting residual risk
- Chris Packard, MD

PACE-CME